Oral Session 3-15C AML: Gemonic Analysis

[OS3-15C-3] Significance of CBFβ/MYH11 during consolidation and risk stratification by WT1 in AML with inv(16)

Akio Mori^1,8, Masahiro Onozawa^2,8, Daisuke Hidaka^2,8, Shinpei Harada^1,8, Reiki Ogasawara^1,8, Koh Izumiyama^1,8, Makoto Saito^1,8, Masanori Tanaka^1,8, Yutaka Tsutsumi^3,8, Shuichi Ota^4,8, Takuto Miyagishima^5,8, Yasutaka Kakinoki^6,8, Hiroshi Iwasaki^7,8, Masanobu Morioka^1,8, Takanori Teshima^2,8, Takeshi Kondo^1,8 (1.Blood Disorders Center, Aiiku Hospital, Sapporo, Japan, 2.Dept. of Hematology, Faculty of Medicine, Hokkaido University, Sapporo, Japan, 3.Dept. of Hematology, Hakodate Municipal Hospital, Hakodate, Japan, 4.Dept. of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan, 5.Dept. of Hematology, Kushiro Rosai Hospital, Kushiro, Japan, 6.Dept. of Hematology, Asahikawa City Hospital, Asahikawa, Japan, 7.Dept. of Hematology, Sapporo Kosei Hospital, Sapporo, Japan, 8.North Japan Hematology Study Group; NJHSG, Sapporo, Japan)